|
"orlando mauro"的相关文件
显示项目 1-6 / 6 (共1页)
1
每页显示[10|25|50]项目
| 臺大學術典藏 |
2019-03-04T08:08:05Z |
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials
|
Cheng, Rebecca;Chung, Hyun Cheol;Orlando, Mauro;Mi, Gu;Binder, Polina;Zhang, Yawei;Sohn, JooHyuk;Yamazaki, Kentaro;Kim, Sang-We;Chao, Yee;Lee, Keun-Wook;Kudo, Masatoshi;Kim, Tae-Won;Muro, Kei;Yen, Chia-Jui;JIN-YUAN SHIH; Yen, Chia-Jui; Muro, Kei; Kim, Tae-Won; Kudo, Masatoshi; JIN-YUAN SHIH; Lee, Keun-Wook; Chao, Yee; Kim, Sang-We; Yamazaki, Kentaro; Sohn, JooHyuk; Cheng, Rebecca; Zhang, Yawei; Binder, Polina; Mi, Gu; Orlando, Mauro; Chung, Hyun Cheol |
| 臺大學術典藏 |
2016-12-01 |
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer
|
Wang, Luhua; Wu, Yi Long; Lu, Shun; Deng, Lei; Ahn, Myung Ju; Hsu, Feng Ming; Iscoe, Neill; Hossain, Anwar; Puri, Tarun; Zhang, Pinghai; Orlando, Mauro |
| 國立成功大學 |
2016-11-15 |
Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis
|
Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Yang, Ling; Abada, Paolo B.; Cheng, Rebecca; Orlando, Mauro; Zhu, Andrew X.; Okusaka, Takuji |
| 國立成功大學 |
2016-03 |
Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer
|
Muro, Kei; Oh, Sang Cheul; Shimada, Yasuhiro; Lee, Keun-Wook; Yen, Chia-Jui; Chao, Yee; Cho, Jae Yong; Cheng, Rebecca; Carlesi, Roberto; Chandrawansa, Kumari; Orlando, Mauro; Ohtsu, Atsushi |
| 國立臺灣大學 |
2015 |
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT
|
Yang, James Chin-Hsin; Ahn, Myung-Ju; Nakagawa, Kazuhiko; Tamura, Tomohide; Barraclough, Helen; Enatsu, Sotaro; Cheng, Rebecca; Orlando, Mauro; 楊志新 |
| 國立臺灣大學 |
2015 |
A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.
|
Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新 |
显示项目 1-6 / 6 (共1页)
1
每页显示[10|25|50]项目
|
